Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human gut metagenome

ABSTRACT: Microbiota in short bowel syndrome

PROVIDER: PRJNA309478 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3119710_1.fastq.gz	Fastqsanger.gz
	SRR3119710_2.fastq.gz	Fastqsanger.gz
	SRR3119720_1.fastq.gz	Fastqsanger.gz
	SRR3119720_2.fastq.gz	Fastqsanger.gz
	SRR3119730_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 66

Similar Datasets

human gut metagenome

Project description:Gut microbiota in short bowel syndrome

| PRJDB4453 | ENA

Relating human gut metagenome and metaproteome

Project description:Gut microbiome research is rapidly moving towards the functional characterization of the microbiota by means of shotgun meta-omics. Here, we selected a cohort of healthy subjects from an indigenous and monitored Sardinian population to analyze their gut microbiota using both shotgun metagenomics and shotgun metaproteomics. We found a considerable divergence between genetic potential and functional activity of the human healthy gut microbiota, in spite of a quite comparable taxonomic structure revealed by the two approaches. Investigation of inter-individual variability of taxonomic features revealed Bacteroides and Akkermansia as remarkably conserved and variable in abundance within the population, respectively. Firmicutes-driven butyrogenesis (mainly due to Faecalibacterium spp.) was shown to be the functional activity with the higher expression rate and the lower inter-individual variability in the study cohort, highlighting the key importance of the biosynthesis of this microbial by-product for the gut homeostasis. The taxon-specific contribution to functional activities and metabolic tasks was also examined, giving insights into the peculiar role of several gut microbiota members in carbohydrate metabolism (including polysaccharide degradation, glycan transport, glycolysis and short-chain fatty acid production). In conclusion, our results provide useful indications regarding the main functions actively exerted by the gut microbiota members of a healthy human cohort, and support metaproteomics as a valuable approach to investigate the functional role of the gut microbiota in health and disease.

2017-07-19 | PXD005780 | Pride

human gut metagenome

Project description:Severe gut microbiota dysbiosis is associated with poor growth in patients with short bowel syndrome

| PRJNA311208 | ENA

human gut metagenome

Project description:gut microbiota in patients with irritable bowel syndrome

| PRJNA563780 | ENA

rat gut metagenome

Project description:Studies of microbial sequencing of a rat short bowel syndrome model.

| PRJDB9356 | ENA

human gut metagenome

Project description:A longitudinal microbiome analysis of glucagon-like peptide-2 (GLP-2) treatment in the patients with short bowel syndrome

| PRJDB20353 | ENA

rat gut metagenome

Project description:Effect of partially hydrolyzed guar gum on gut microbiota in a rat model of short bowel syndrome.

| PRJDB8061 | ENA

Colonic Gene expression in mice colonized with human gut microbiota from healthy and IBS patients

Project description:Irritable Bowel Syndrome (IBS) is a disorder of the gut-brain axis, characterized by altered gut function and frequent psychiatric co-morbidity. Although altered intestinal microbiome profiles have been documented, their relevance to the clinical expression of IBS is unknown. To evaluate a functional role of the microbiota, we colonized germ-free mice with fecal microbiota from healthy controls or IBS patients with accompanying anxiety, and monitored gut function and behavior. Mouse microbiota profiles clustered according to their human donors. Despite having taxonomically similar composition as controls, mice with IBS microbiota had distinct serum metabolomic profiles related to neuro- and immunomodulation. Mice with IBS, but not control microbiota, exhibited faster gastrointestinal transit, intestinal barrier dysfunction, innate immune activation and anxiety-like behavior. These results support the notion that the microbiota contributes to both intestinal and behavioral manifestations of IBS and rationalize the use of microbiota-directed therapies in ameliorating IBS.

2017-03-02 | GSE61841 | GEO

human gut metagenome

Project description:Gut microbiome correlates of psychological stress in irritable bowel syndrome

| PRJNA386442 | ENA

human gut metagenome

Project description:Human Gut Microbiome of Irritable Bowel Syndrome Patients from Pakistan

| PRJNA836395 | ENA